LP
LGL Partners’s Sarepta Therapeutics SRPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-4,196
| Closed | -$543K | – | 120 |
|
2024
Q1 | $543K | Hold |
4,196
| – | – | 0.09% | 66 |
|
2023
Q4 | $405K | Hold |
4,196
| – | – | 0.06% | 75 |
|
2023
Q3 | $509K | Buy |
4,196
+186
| +5% | +$22.5K | 0.09% | 65 |
|
2023
Q2 | $459K | Buy |
4,010
+370
| +10% | +$42.4K | 0.08% | 72 |
|
2023
Q1 | $502K | Sell |
3,640
-346
| -9% | -$47.7K | 0.09% | 62 |
|
2022
Q4 | $517K | Sell |
3,986
-25
| -0.6% | -$3.24K | 0.09% | 55 |
|
2022
Q3 | $443K | Buy |
+4,011
| New | +$443K | 0.09% | 68 |
|
2017
Q3 | – | Sell |
-8,887
| Closed | -$300K | – | 83 |
|
2017
Q2 | $300K | Hold |
8,887
| – | – | 0.16% | 72 |
|
2017
Q1 | $263K | Hold |
8,887
| – | – | 0.13% | 76 |
|
2016
Q4 | $244K | Hold |
8,887
| – | – | 0.13% | 84 |
|
2016
Q3 | $542K | Sell |
8,887
-3,975
| -31% | -$242K | 0.28% | 42 |
|
2016
Q2 | $269K | Sell |
12,862
-12,000
| -48% | -$251K | 0.15% | 81 |
|
2016
Q1 | $485K | Buy |
24,862
+1,000
| +4% | +$19.5K | 0.25% | 53 |
|
2015
Q4 | $921K | Buy |
+23,862
| New | +$921K | 0.5% | 35 |
|